US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults
If approved, Actemra/RoActemra would be the first US FDA-approved immunomodulator for the treatment of COVID-19 in hospitalised…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Actemra/RoActemra
WHO grants prequalification of Roche’s Actemra/RoActemra for patients with severe COVID
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra,…
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase-III studies.…